Oncolytic Activity and Mechanisms of Action by a small β2,2-amino acid derivative LTX-401
Antimicrobial peptides are part of the innate immune defence of many organisms and represent a novel class of therapeutics due to their broad-spectrum activities, including cytotoxic activity against cancer cells. It has recently been reported that small antimicrobial β2,2-amino acid derivatives (Mw<500), such as LTX-401, possess potent anticancer activity against Ramos human Burkitt’s lymphoma cells. In the present thesis, the anticancer properties displayed by LTX-401 became subject for a continued investigation. In vitro cytotoxicity studies revealed that LTX-401 was highly active against a panel of malignant cells including murine and human cancer cell lines. Moreover, LTX-401 was found to induce known features of immunogenic cell death as shown by the release of Damage-Associated Molecular Pattern molecules such as High-Mobility Group Box-1 protein, adenosine triphosphate and cytochrome c in vitro. Intralesional administration of LTX-401 into intradermally established B16 melanomas in syngeneic mice resulted in complete regression of the tumor. Moreover, cured animals that were given a second tumor challenge with live B16F1 cells did not develop tumor and displayed immune protection against the cancer. Altogether, these results underscore the therapeutic potential of LTX-401 in conveying local tumor control and generation of protective immunity, presumably by the engagement of immunogenic cell death.
PublisherUiT Norges arktiske universitet
UiT The Arctic University of Norway
The following license file are associated with this item: